Plain-English translation of NCT04170244 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Atopic Dermatitis research guide →Researchers want to understand how bacteria on the skin of people with eczema and psoriasis change over time as they receive treatment. Scientists know that certain bacteria—especially one called Staphylococcus aureus—may play a role in these skin conditions, but they don't yet know exactly how treatment affects these bacteria or how they relate to getting better. This study will collect skin samples from patients receiving routine dermatology care to map these changes.
Even though we have good treatments for eczema and psoriasis today, we still don't fully understand what happens to the bacteria on the skin as patients improve. Identifying biomarkers—measurable signs that show who has high levels of harmful bacteria or who will respond well to treatment—could help doctors predict outcomes and personalize care in the future.
You likely qualify if…
You likely don't qualify if…
If you have eczema or psoriasis, you will continue receiving whatever treatment your dermatologist at the University of Rochester Medical Center recommends as part of your regular care. Researchers will collect skin samples (by gentle swabbing or tape stripping) at study visits to track changes in the bacteria on your skin as you receive treatment. Healthy volunteers will provide skin samples once to serve as comparison. The study is ongoing and will follow patients over time to see how their skin bacteria change alongside their clinical improvement.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
United States